Dendritic Cells From the Cervical Mucosa Capture and Transfer HIV-1 via Siglec-1.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 10 01 2019
accepted: 28 03 2019
entrez: 23 5 2019
pubmed: 23 5 2019
medline: 30 9 2020
Statut: epublish

Résumé

Antigen presenting cells from the cervical mucosa are thought to amplify incoming HIV-1 and spread infection systemically without being productively infected. Yet, the molecular mechanism at the cervical mucosa underlying this viral transmission pathway remains unknown. Here we identified a subset of HLA-DR

Identifiants

pubmed: 31114569
doi: 10.3389/fimmu.2019.00825
pmc: PMC6503733
doi:

Substances chimiques

Interferon Type I 0
SIGLEC1 protein, human 0
Sialic Acid Binding Ig-like Lectin 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

825

Références

Cell. 2000 Mar 3;100(5):587-97
pubmed: 10721995
J Virol. 2000 Jul;74(13):6087-95
pubmed: 10846092
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1568-73
pubmed: 11818554
J Virol. 2002 Aug;76(15):7812-21
pubmed: 12097593
Nat Immunol. 2002 Oct;3(10):975-83
pubmed: 12352970
Int Immunol. 2003 Feb;15(2):289-98
pubmed: 12578859
J Virol. 2003 Mar;77(6):3777-84
pubmed: 12610152
Science. 2003 May 23;300(5623):1295-7
pubmed: 12730499
Science. 1992 Jul 17;257(5068):383-7
pubmed: 1352913
J Virol. 2003 Dec;77(23):12865-74
pubmed: 14610207
Blood. 2004 Mar 15;103(6):2170-9
pubmed: 14630806
Nat Rev Microbiol. 2003 Oct;1(1):25-34
pubmed: 15040177
J Exp Med. 2004 Apr 19;199(8):1065-75
pubmed: 15078900
J Leukoc Biol. 2004 Oct;76(4):804-11
pubmed: 15258189
J Virol. 2005 Jul;79(14):9217-27
pubmed: 15994816
J Virol. 2005 Oct;79(19):12164-72
pubmed: 16160143
J Immunol. 2005 Oct 1;175(7):4265-73
pubmed: 16177066
J Clin Invest. 2005 Nov;115(11):3265-75
pubmed: 16224540
J Virol. 2005 Nov;79(22):14355-70
pubmed: 16254370
J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):137-43
pubmed: 16940859
J Immunol. 2006 Dec 1;177(11):7510-4
pubmed: 17114418
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
J Virol. 2007 Mar;81(5):2519-23
pubmed: 17182696
Annu Rev Immunol. 2007;25:381-418
pubmed: 17378762
J Virol. 2007 Jul;81(14):7559-70
pubmed: 17475656
J Virol. 2007 Sep;81(17):8933-43
pubmed: 17567699
PLoS One. 2008 Apr 16;3(4):e1967
pubmed: 18414664
PLoS Pathog. 2008 Aug 22;4(8):e1000134
pubmed: 18725936
Clin Microbiol Infect. 2009 Jan;15(1):50-9
pubmed: 19046168
Nature. 2009 Apr 23;458(7241):1034-8
pubmed: 19262509
Nat Med. 2009 Aug;15(8):955-9
pubmed: 19597505
Nature. 2010 Mar 11;464(7286):217-23
pubmed: 20220840
Nat Rev Immunol. 2010 Oct;10(10):699-711
pubmed: 20829886
J Reprod Immunol. 2011 Mar;88(2):185-94
pubmed: 21353708
J Virol. 2011 Dec;85(24):13443-7
pubmed: 21976645
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7475-80
pubmed: 22529395
PLoS Biol. 2012;10(4):e1001315
pubmed: 22545022
Mucosal Immunol. 2013 May;6(3):626-38
pubmed: 23131784
PLoS Biol. 2012;10(12):e1001448
pubmed: 23271952
Immunity. 2013 Feb 21;38(2):336-48
pubmed: 23352235
PLoS Pathog. 2013;9(4):e1003291
pubmed: 23593001
J Infect Dis. 2013 Sep 1;208(5):830-8
pubmed: 23757341
Am J Reprod Immunol. 2014 Mar;71(3):252-64
pubmed: 24410939
J Virol. 2014 Jul;88(13):7683-8
pubmed: 24741097
PLoS Pathog. 2014 Oct 09;10(10):e1004440
pubmed: 25299616
Nat Rev Microbiol. 2015 Jul;13(7):403-13
pubmed: 25915633
Retrovirology. 2015 May 07;12:37
pubmed: 25947229
Science. 2015 Oct 30;350(6260):563-567
pubmed: 26429886
Clin Transl Immunology. 2015 Oct 09;4(10):e43
pubmed: 26682051
Cell Host Microbe. 2016 Apr 13;19(4):529-40
pubmed: 27078070
Mucosal Immunol. 2017 Mar;10(2):531-544
pubmed: 27579858
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599
pubmed: 28069935
Front Immunol. 2018 Jan 15;8:1823
pubmed: 29379496
J Immunol Methods. 2018 Sep;460:26-35
pubmed: 29894750
Front Immunol. 2018 Nov 23;9:2719
pubmed: 30532754
Cell. 1994 Aug 12;78(3):389-98
pubmed: 7914836
J Exp Med. 1996 Jan 1;183(1):215-25
pubmed: 8551225
J Virol. 1998 Oct;72(10):7822-9
pubmed: 9733818

Auteurs

Daniel Perez-Zsolt (D)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.

Jon Cantero-Pérez (J)

Department of Infectious Diseases, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.

Itziar Erkizia (I)

IrsiCaixa AIDS Research Institute, Badalona, Spain.

Susana Benet (S)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.

Maria Pino (M)

IrsiCaixa AIDS Research Institute, Badalona, Spain.

Carla Serra-Peinado (C)

Department of Infectious Diseases, Vall d'Hebron Institut de Recerca, Barcelona, Spain.

Alba Hernández-Gallego (A)

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.
Pathology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Josep Castellví (J)

Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Department of Morphological Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain.

Gustavo Tapia (G)

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.
Pathology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Department of Morphological Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain.

Vicent Arnau-Saz (V)

Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Department of Infectious Diseases, Vall d'Hebron Institut de Recerca, Barcelona, Spain.

Julio Garrido (J)

Hospital Municipal de Badalona, Badalona, Spain.

Antoni Tarrats (A)

Department of Obstetrics and Gynecology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Maria J Buzón (MJ)

Department of Infectious Diseases, Vall d'Hebron Institut de Recerca, Barcelona, Spain.

Javier Martinez-Picado (J)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.
Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.

Nuria Izquierdo-Useros (N)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.

Meritxell Genescà (M)

Department of Infectious Diseases, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH